Stockholm

Stockholm has emerged as a premier global life sciences hub, renowned for its seamless integration of academic research, clinical excellence and industrial scale.

At the heart of this ecosystem is the world-leading Karolinska Institutet, which, alongside the Karolinska University Hospital, drives groundbreaking discoveries in pharmaceutical development and biotechnology.

The region is a pioneer in precision medicine and advanced therapy medicinal products (ATMPs), supported by Sweden’s unique national health data registries and biobanks.

Within the vibrant Hagastaden district, global giants like AstraZeneca and Pfizer collaborate with agile biotech startups in a dense, innovation-driven cluster.

Stockholm is also a leader in medical device (medtech) engineering, leveraging the city’s world-class ICT sector to advance digital health and AI-driven diagnostics.

The SciLifeLab serves as a national focal point for molecular biosciences, providing state-of-the-art infrastructure for high-throughput research.

Significant investments in biomanufacturing and sustainable production ensure the region remains a top destination for international investors and life science talent.

By fostering a "molecule to market" approach, the Stockholm-Uppsala life science cluster continues to set the standard for healthcare innovation that addresses global medical challenges.

This collaborative environment ensures that breakthroughs in the lab are rapidly translated into life-saving treatments for patients worldwide.